Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2012
11/27/2012CA2359360C In vitro screening method for identifying selective binding partners for 5-ht5-receptors
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/22/2012WO2012157737A1 Immunity inducing agent
11/22/2012WO2012157736A1 Immunity induction agent
11/22/2012WO2012157721A1 Liposome containing pyrroloquinoline quinone and sugar
11/22/2012WO2012157672A1 Method for predicting effectiveness of angiogenesis inhibitor
11/22/2012WO2012157647A1 Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor
11/22/2012WO2012157612A1 Cell differentiation inducer and differentiation inducing method
11/22/2012WO2012157587A1 Anti-wrinkle agent, matrix metalloproteinase (mmp) inhibitor and/or laminin 5 production promoter, each comprising 1-piperidine propionate
11/22/2012WO2012157389A1 Low-molecular-weight compound capable of regulating rac activation induced by dock-a subfamily molecule, and use thereof
11/22/2012WO2012157288A1 Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran-4-carboxylic acid
11/22/2012WO2012157237A1 Osteogenesis promoter
11/22/2012WO2012156225A1 Use of a sulfurated compound for the treatment of hyper-homocysteinemia.
11/22/2012WO2012059882A3 Engineered polypeptide conjugates and methods for making thereof using transglutaminase
11/22/2012US20120296263 Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris
11/22/2012US20120296088 Synthesis of udp-glucose: n-acylsphingosine glucosyl transferase inhibitors
11/22/2012US20120295954 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
11/22/2012US20120295902 Hetaryl-[1,8]naphthyridine derivatives
11/22/2012US20120295893 Compositions and methods of counteracting residual sedative effects of sleep/ hypnotic drugs
11/22/2012US20120295890 Glycosaminoglycan inhibitors
11/22/2012US20120295888 Use of an adrenal hormone-modifying agent
11/22/2012US20120295856 Fredericamycin derivatives
11/22/2012US20120295855 Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug
11/22/2012US20120295836 GLP-I Agonist And Cardiovascular Complications
11/22/2012US20120294865 Integrin Alpha-2 Binding Agents and Use Thereof to Inhibit Cancer Cell Proliferation
11/22/2012US20120292797 Solid pharmaceutical dispersions with enhanced bioavailability
11/22/2012CA2836568A1 Immunity induction agent
11/22/2012CA2836556A1 Immunity induction agent
11/22/2012CA2836372A1 Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran-4-carboxylic acid
11/21/2012EP2524697A1 Therapeutic agent for promoting recovery of animal under medical treatment
11/21/2012EP2524693A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
11/21/2012CN1891716B No mitogen activity anti CD3 small molecular antibody designing method
11/21/2012CN102791719A Crystal of diamine derivative and method of producing same
11/21/2012CN102791274A Epithelial cell-cell adhesion enhancer, and ameliorating, therapeutic or prophylactic agent for allergic diseases using same
11/21/2012CN102791268A Treating critically ill patients with intravenous ibuprofen
11/21/2012CN102786572A Ribavirin crystal C characterization and preparation methods, and applications of Ribavirin crystal C in medicines and healthcare products
11/21/2012CN102786571A Ribavirin crystal D, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102784387A Modified mutant collagenase and it's use in fat melting and in scar reduction
11/21/2012CN102784383A Methods for preventing mitochondrial permeability transition
11/21/2012CN102784322A Organism breeding agent
11/21/2012CN102274400B Dry jewel orchid and processing method thereof
11/21/2012CN102030817B Peptide for inhibiting angiontensin converting enzyme
11/21/2012CN102020649B Diketopiperazine compound as well as composition, preparation method and application thereof
11/21/2012CN101980716B Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents
11/21/2012CN101912382B 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
11/21/2012CN101484443B Potentiator of radiation therapy
11/21/2012CN101432280B Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
11/21/2012CN101396384B Asiatic centella extract and preparation methode thereof
11/21/2012CN101272803B Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink
11/21/2012CN101039663B STAT3 phosphorylation inhibitor and notch 1 expression inhibitor
11/20/2012US8314104 Method of treating diabetes
11/20/2012US8314079 Hyaluronic acid oligosaccharide fractions and drugs containing the same
11/20/2012US8314074 Formulations comprising antisense nucleotides to connexins
11/20/2012US8314067 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
11/20/2012US8313913 Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa
11/20/2012US8313732 Formoterol superfine formulation
11/20/2012CA2693180C Fused bicyclic compound
11/20/2012CA2583699C Stat3 phosphorylation inhibitor and notch1 expression inhibitor
11/20/2012CA2529878C Pyrazole derivative, drug composition containing the same and production intermediate therefor
11/20/2012CA2492989C Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
11/20/2012CA2482466C Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
11/20/2012CA2398983C Pharmaceutical composition to prevent tissue damage due to arterial blood flow failure
11/20/2012CA2335362C Use of a dipeptide for stimulating repair processes
11/20/2012CA2318095C Methods of treating tardive dyskinesia and other movement disorders
11/15/2012WO2012155061A1 Use of arsenic for cancer therapy protection
11/15/2012WO2012154505A1 Compositions comprising hydrogel particles
11/15/2012WO2012153827A1 Stable drug composition
11/15/2012WO2012153620A1 Drug, functional food, method for stabilizing target protein, fused protein, nucleic acid, and recombinant
11/15/2012WO2012153616A1 Lipid membrane structure capable of imigrating to target cell and method for producing same, and method for screening for substance exhibiting effect thereof in target cell
11/15/2012WO2012153302A1 Antipyretics to enhance tolerability of vesicle-based vaccines
11/15/2012WO2012153273A1 A process for delivering encapsulated neutral bioimaging molecules, complex, and process thereof
11/15/2012WO2012153110A1 Use of bethanechol for treatment of xerostomia
11/15/2012WO2012153071A2 Polysaccharides having a variable degree of functionalization
11/15/2012US20120289552 Aryl ureas with angiogenesis inhibiting activity
11/15/2012US20120288567 Opioid Agonist Formulations with Releasable And Sequestered Antagonist
11/15/2012US20120288565 Tamper-resistant oral opioid agonist formulations
11/15/2012US20120288542 Solid pharmaceutical dispersions with enhanced bioavailability
11/15/2012US20120288441 Injectable biodegradable particles
11/15/2012CA2835631A1 Use of arsenic for cancer therapy protection
11/14/2012EP2522657A1 Indole derivative
11/14/2012EP2522355A1 Dna damage repair promoter for oral application, and elastase activity inhibitor for oral application
11/14/2012EP2521453A1 Methods and compositions for the treatment of migraine headaches
11/14/2012CN1675250B Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
11/14/2012CN1434795B Acyl pseudodipeptides which carry a functionalised auxiliary arm
11/14/2012CN102781943A Benzodiazepine bromodomain inhibitor
11/14/2012CN102781914A Indole derivative
11/14/2012CN102781910A Alkylamine derivative
11/14/2012CN102781460A Agent for preventing muscular atrophy
11/14/2012CN102781457A Immunoglobulin A secretion promoter
11/14/2012CN102781443A Apremilast For The Treatment Of Sarcoidosis
11/14/2012CN102775396A Modulators of ATP-binding cassette transporters
11/14/2012CN102772691A Application of honeysuckle flower Miyanling in preparing reverse Staphylococcus aureus drug resistance medicine
11/14/2012CN102772688A Tablets for clearing summer-heat and tonifying qi
11/14/2012CN102772581A Medicine for preventing porcine reproductive and respiratory syndrome
11/14/2012CN102772571A Lycium chinense, fructus ligustri lucidi and herba celiptae wine
11/14/2012CN102772503A Medicine for preventing porcine reproductive and respiratory syndrome
11/14/2012CN102772493A Tablets for clearing summer-heat to relieve superficies syndrome
11/14/2012CN102060911B Polypeptide combined with various amyloid protein monomers simultaneously and application thereof
11/14/2012CN102014905B Donepezil-containing patch preparation and packaging thereof
11/14/2012CN101892237B Polynucleotide related to mitochondrial membrane potential decrease and coded polypeptide and application thereof
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 1564